RES vs. BTCY

Last updated Jun 23, 2026

RES (RPC, Inc.) and BTCY (Biotricity, Inc.) are both stocks. RES operates in Oil & Gas Equipment & Services (Energy), while BTCY operates in Medical Devices (Healthcare). At a 0.31 correlation, their price movements are largely independent.

Performance

RES vs. BTCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RPC, Inc. (RES) and Biotricity, Inc. (BTCY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RES

• 1D: -1.67%
• 1M: -8.36%
• YTD: 20.48%
• 6M: 17.88%
• 1Y: 29.58%
• 3Y*: -0.04%
• 5Y*: 5.07%
• 10Y*: -6.73%

BTCY

• 1D: -0.12%
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

RES vs. BTCY - Yearly Performance Comparison

	2026 (YTD)
RES RPC, Inc.	-9.13%
BTCY Biotricity, Inc.	-4.21%

Correlation

The correlation between RES and BTCY is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 4, 2026	0.31

Fundamentals

Market Cap RES : $1.43B BTCY : $113.12M
EPS RES : $0.10 BTCY : -$0.17
PS Ratio RES : 0.81 BTCY : 7.09
Total Revenue (TTM) RES : $1.75B BTCY : $15.45M
Gross Profit (TTM) RES : $242.68M BTCY : $12.53M
EBITDA (TTM) RES : $218.68M BTCY : $267.47K

Return for Risk

RES vs. BTCY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RES

RES Risk / Return Rank: 63
RES Sharpe Ratio Rank: 63
RES Sortino Ratio Rank: 58
RES Omega Ratio Rank: 58
RES Calmar Ratio Rank: 69
RES Martin Ratio Rank: 67

BTCY

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RES vs. BTCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RPC, Inc. (RES) and Biotricity, Inc. (BTCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RES	BTCY	Difference
Sharpe ratio: Return per unit of total volatility	0.63	—	—
Sortino ratio: Return per unit of downside risk	1.11	—	—
Omega ratio: Gain probability vs. loss probability	1.15	—	—
Calmar ratio: Return relative to maximum drawdown	1.43	—	—
Martin ratio: Return relative to average drawdown	2.93	—	—

Drawdowns

RES vs. BTCY - Drawdown Comparison

The maximum RES drawdown since its inception was -92.34%, which is greater than BTCY's maximum drawdown of -6.78%. Use the drawdown chart below to compare losses from any high point for RES and BTCY.

Drawdown Indicators

	RES	BTCY	Difference
Max Drawdown Largest peak-to-trough decline	-92.34%	-6.78%	-85.56%
Max Drawdown (1Y) Largest decline over 1 year	-20.83%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-63.75%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-92.34%	—	—
Current Drawdown Current decline from peak	-72.24%	-4.21%	-68.03%
Average Drawdown Average peak-to-trough decline	-37.53%	-3.48%	-34.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.18%	—	—

Volatility

Volatility by Period

	RES	BTCY	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.05%	—	—
Volatility (6M) Calculated over the trailing 6-month period	36.62%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	47.07%	67.93%	-20.86%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	52.78%	67.93%	-15.15%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	57.31%	67.93%	-10.62%

Dividends

RES vs. BTCY - Dividend Comparison

RES's dividend yield for the trailing twelve months is around 2.47%, while BTCY has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BTCY Biotricity, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
RES RPC, Inc.	2.47%	2.94%	2.69%	2.20%	0.45%	0.00%	0.00%	2.86%	4.76%	0.51%	0.25%	1.30%

Financials

RES vs. BTCY - Profitability Comparison

The chart below illustrates the profitability comparison between RPC, Inc. and Biotricity, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

RES - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, RPC, Inc. reported a gross profit of 99.17M and revenue of 454.76M. Therefore, the gross margin over that period was 21.8%.

BTCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Biotricity, Inc. reported a gross profit of 3.25M and revenue of 3.99M. Therefore, the gross margin over that period was 81.5%.

RES - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, RPC, Inc. reported an operating income of 2.62M and revenue of 454.76M, resulting in an operating margin of 0.6%.

BTCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Biotricity, Inc. reported an operating income of 440.92K and revenue of 3.99M, resulting in an operating margin of 11.1%.

RES - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, RPC, Inc. reported a net income of 855.00K and revenue of 454.76M, resulting in a net margin of 0.2%.

BTCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Biotricity, Inc. reported a net income of -1.15M and revenue of 3.99M, resulting in a net margin of -28.8%.

Frequently Asked Questions

Can I hold both RES and BTCY in my portfolio?

RES and BTCY have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.